1. Home
  2. SVII vs SMTI Comparison

SVII vs SMTI Comparison

Compare SVII & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVII
  • SMTI
  • Stock Information
  • Founded
  • SVII 2021
  • SMTI 1982
  • Country
  • SVII United States
  • SMTI United States
  • Employees
  • SVII N/A
  • SMTI N/A
  • Industry
  • SVII Blank Checks
  • SMTI Medical/Dental Instruments
  • Sector
  • SVII Finance
  • SMTI Health Care
  • Exchange
  • SVII Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • SVII 116.6M
  • SMTI 252.1M
  • IPO Year
  • SVII 2022
  • SMTI N/A
  • Fundamental
  • Price
  • SVII $11.87
  • SMTI $27.95
  • Analyst Decision
  • SVII
  • SMTI Strong Buy
  • Analyst Count
  • SVII 0
  • SMTI 2
  • Target Price
  • SVII N/A
  • SMTI $49.50
  • AVG Volume (30 Days)
  • SVII 5.3K
  • SMTI 55.5K
  • Earning Date
  • SVII 01-01-0001
  • SMTI 08-11-2025
  • Dividend Yield
  • SVII N/A
  • SMTI N/A
  • EPS Growth
  • SVII N/A
  • SMTI N/A
  • EPS
  • SVII 0.25
  • SMTI N/A
  • Revenue
  • SVII N/A
  • SMTI $91,569,883.00
  • Revenue This Year
  • SVII N/A
  • SMTI $23.53
  • Revenue Next Year
  • SVII N/A
  • SMTI $5.93
  • P/E Ratio
  • SVII $47.86
  • SMTI N/A
  • Revenue Growth
  • SVII N/A
  • SMTI 34.65
  • 52 Week Low
  • SVII $11.06
  • SMTI $25.86
  • 52 Week High
  • SVII $11.90
  • SMTI $39.08
  • Technical
  • Relative Strength Index (RSI)
  • SVII 63.77
  • SMTI 48.14
  • Support Level
  • SVII $11.64
  • SMTI $28.71
  • Resistance Level
  • SVII $11.78
  • SMTI $30.94
  • Average True Range (ATR)
  • SVII 0.09
  • SMTI 1.02
  • MACD
  • SVII 0.02
  • SMTI 0.10
  • Stochastic Oscillator
  • SVII 100.00
  • SMTI 39.81

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: